Systems vaccinology: its promise and challenge for HIV vaccine development
HI Nakaya, B Pulendran - Current opinion in HIV and AIDS, 2012 - journals.lww.com
Current opinion in HIV and AIDS, 2012•journals.lww.com
High-throughput technologies allow the investigation of vaccine-induced immune responses
at system and molecular levels. These are currently being used to unravel new molecular
insights about the immune system, and are on the verge of being integrated into clinical
trials to enable rational vaccine design and development.
at system and molecular levels. These are currently being used to unravel new molecular
insights about the immune system, and are on the verge of being integrated into clinical
trials to enable rational vaccine design and development.
Summary
High-throughput technologies allow the investigation of vaccine-induced immune responses at system and molecular levels. These are currently being used to unravel new molecular insights about the immune system, and are on the verge of being integrated into clinical trials to enable rational vaccine design and development.
Lippincott Williams & Wilkins